Targeting Norovirus Infection-Multivalent Entry Inhibitor Design Based on NMR Experiments

Noroviruses attach to their host cells through histo blood group antigens (HBGAs), and compounds that interfere with this interaction are likely to be of therapeutic or diagnostic interest. It is shown that NMR binding studies can simultaneously identify and differentiate the site for binding HBGA ligands and complementary ligands from a large compound library, thereby facilitating the design of potent heterobifunctional ligands. Saturation transfer difference (STD) NMR experiments, spin‐lock filtered NMR experiments, and interligand NOE (ILOE) experiments in the presence of virus‐like particles (VLPs), identified compounds that bind to the HBGA binding site of human norovirus. Based on these data two multivalent prototype entry‐inhibitors against norovirus infection were synthesized. A surface plasmon resonance based inhibition assay showed avidity gains of 1000 and one million fold over a millimolar univalent ligand. This suggests that further rational design of multivalent inhibitors based on our strategy will identify potent entry‐inhibitors against norovirus infections. Entry inhibitor from NMR data: NMR spectroscopy identifies compounds that bind to noroviruses. Multimeric presentation leads to high avidity inhibitors.